Implants News and Research

RSS

WRAIR to test Kane Biotech's DispersinB biofilm technology against pathogens in combat trauma wounds

Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that the Company has entered into a Cooperative Research and Development Agreement for Material Transfer (CRADA-MT) with the Walter Reed Army Institute of Research (WRAIR) in Silver Springs, Maryland.

9 Sep 2009

European Dynamic Annuloplasty Activation study completes patient enrollment

MiCardia (MiCardia Corporation, Irvine, California) today announced the completion of enrollment in its European “DYANA” (Dynamic Annuloplasty Activation) study, designed to support submission for CE mark of the firm’s Dynaplasty technology in Europe.

9 Sep 2009

Astra Tech launches Atlantis patient-specific abutments in shaded zirconia

Astra Tech announces the launch of Atlantis™ patient-specific abutments in shaded zirconia. The new option for Atlantis abutments, in addition to the already existing materials of titanium, gold-shaded titanium and zirconia, offers clinicians the freedom and flexibility to provide their patients with truly esthetic results.

9 Sep 2009

New procedure for transapical valve replacement minimizes trauma and blood loss

Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.

9 Sep 2009

FDA approves Cochlear's Nucleus 5 System

Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus((R) )5 System for adults and children with severe-to-profound hearing loss.

9 Sep 2009

Bacterial cells could contribute to stronger bone implants

Bacteria that manufacture hydroxyapatite (HA) could be used to make stronger, more durable bone implants. Professor Lynne Macaskie from the University of Birmingham this week (7-10 September) presented work to the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh.

7 Sep 2009

Recession impacts dental implant industry

Tooth loss among the elderly population will create some growth in the $3 billion global dental implant market despite the recession, according to "Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, 3rd Edition" by premier life sciences market research publisher Kalorama Information, though not the impressive double digit growth rates of prior years.

5 Sep 2009

PASS LP spinal system for treating complex deformities receives FDA approval

MEDICREA announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market the PASS LP Iliac Fixation within the United States. This new Iliac Fixation supplements the PASS LP range, a ultra Low Profile Polyaxial Spine System launched recently.

4 Sep 2009

New radial head plates to be launched by Medartis at the ASSH, in San Francisco

Medartis, Inc. will introduce the Company’s new Radial Head Plates at this year’s American Society for Surgery of the Hand (ASSH) annual meeting beginning today, September 3, 2009, in San Francisco at the Moscone West Convention Center. During the show, Medartis staff will be on site, Booth #137, to demonstrate and discuss the new product as well as the Company’s expanded line of Medartis products.

3 Sep 2009

Boston Scientific reports two-year data from SYNTAX clinical trial

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific (NYSE: BSX), has reported two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention (PCI) using the Taxus(R) Express(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery.

3 Sep 2009

Uroplasty highlights the result of OrBIT trial of its Urgent PC System

Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT trial of its Urgent PC System.

3 Sep 2009

CRT-D implants for treating sudden cardiac death

Electrophysiologists Robert Stevenson, MD, and Jeffrey L. Williams, MD, MS, FACC, are safely implanting cardiac resynchronization therapy defibrillators in the Good Samaritan Hospital (GSH) Cardiology (Heart Failure) Program.

3 Sep 2009

Neuronetics raises funds to expand sales team for NeuroStar TMS Therapy

New Leaf Venture Partners (NLV Partners) announced today it has led a $30 million Series D financing round in Neuronetics, Inc., maker of NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® for the treatment of depression.

3 Sep 2009

IDEAL IMPLANT clinical trial features lump-sum payment to participants

A clinical trial of the IDEAL IMPLANT Saline-filled Breast Implant offered Teri a new “hybrid” design, combining both the natural result of silicone gel with the safety of saline for peace of mind. The trial also features a unique lump-sum payment to participants from a trust fund.

3 Sep 2009

Implanet to use IBM's sensor technology for its new implant device tracking service

Implanet, a manufacturer of implantable medical devices, has selected IBM (NYSE: IBM) sensor technology as the foundation for BeepN'Track, a new service that traces the movement of Implanet's products - including knee and hip implants - across its supply chain to hospitals.

3 Sep 2009

CardioWest Total Artificial Heart recipient going strong for more than 10 months

Over the last five years, Jim Hennigan has had four different hearts beating in his chest… the heart he was born with, two donor hearts and a Total Artificial Heart.

2 Sep 2009

Patient enrollment completed for the Berlin Heart EXCOR Pediatric IDE clinical study

Berlin Heart Inc. reported today that it has completed enrollment in Cohort 1 of the Berlin Heart EXCOR(R) Pediatric IDE Study after having received unconditional approval of the study from the FDA in November 2008.

2 Sep 2009

TriboFit Hip System receives CE Class III Certificate

Active Implants Corporation (AIC) today announced that it has received a CE Class III Certificate for its TriboFit® Hip System.

1 Sep 2009

Lack of imagination and aversion to commercial risk are the biggest threats to Australia’s medical innovation

Australia could be a world leader in medical innovation but commercial risk aversion and parochialism are holding the industry back, a leading venture capitalist will argue at a public lecture and debate at the University of New South Wales next week (Monday, 31 August).

26 Aug 2009

Saint Vincent Hospital adds RF Surgical Detection System to surgical safety protocols

Saint Vincent Hospital in Worcester, Massachusetts has joined a growing number of over 100 hospitals nationwide to add the RF Surgical Detection System to its surgical safety protocols. This patented and FDA-approved technology uses a scanning wand that detects and signals an alert if any radio frequency tagged surgical sponges remain in a patient following surgery

26 Aug 2009